Literature DB >> 3709633

The intra- and inter-subject variability of nifedipine pharmacokinetics in young volunteers.

J Lobo, D B Jack, M J Kendall.   

Abstract

Plasma concentrations of Nifedipine were measured following single oral doses of Nifedipine Slow Release (Adalat Retard) on three separate occasions to young, healthy volunteers of both sexes. Intra- and inter-subject variability were assessed by comparing the pharmacokinetic parameters, AUC, Cmax and T50%AUC. Interindividual variability was less than that observed in other studies with the beta-blockers, metoprolol and propranolol and there was no evidence of differences between the sexes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3709633     DOI: 10.1007/bf00614196

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  7 in total

1.  Variability of beta-blocker pharmacokinetics in young volunteers.

Authors:  D B Jack; C P Quarterman; R Zaman; M J Kendall
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

2.  Variability in nifedipine pharmacokinetics and dynamics: a new oxidation polymorphism in man.

Authors:  C H Kleinbloesem; P van Brummelen; H Faber; M Danhof; N P Vermeulen; D D Breimer
Journal:  Biochem Pharmacol       Date:  1984-11-15       Impact factor: 5.858

3.  Determination of nifedipine in human plasma by capillary gas chromatography with nitrogen detection.

Authors:  M T Rosseel; M G Bogaert
Journal:  J Chromatogr       Date:  1983-11-25

4.  Lack of a pharmacokinetic interaction between nifedipine and the beta-adrenoceptor blockers metoprolol and atenolol.

Authors:  M J Kendall; D B Jack; S J Laugher; J Lobo; S Rolf Smith
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

5.  Nifedipine: kinetics and dynamics in healthy subjects.

Authors:  C H Kleinbloesem; P van Brummelen; J A van de Linde; P J Voogd; D D Breimer
Journal:  Clin Pharmacol Ther       Date:  1984-06       Impact factor: 6.875

6.  Nifedipine in the treatment of difficult hypertensives.

Authors:  S Dean; M J Kendall
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Nifedipine and propranolol: a beneficial drug interaction.

Authors:  H J Dargie; P G Lynch; D M Krikler; L Harris; S Krikler
Journal:  Am J Med       Date:  1981-10       Impact factor: 4.965

  7 in total
  10 in total

Review 1.  Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.

Authors:  Mei-Ling Chen
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 2.  Clinical significance of genetic influences on cardiovascular drug metabolism.

Authors:  L Arcavi; N L Benowitz
Journal:  Cardiovasc Drugs Ther       Date:  1993-06       Impact factor: 3.727

Review 3.  Ranitidine versus cimetidine. A comparison of their potential to cause clinically important drug interactions.

Authors:  S R Smith; M J Kendall
Journal:  Clin Pharmacokinet       Date:  1988-07       Impact factor: 6.447

Review 4.  Gender differences in pharmacokinetics.

Authors:  C H Gleiter; U Gundert-Remy
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

Review 5.  Gender effects in pharmacokinetics and pharmacodynamics.

Authors:  R Z Harris; L Z Benet; J B Schwartz
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

6.  Factors affecting the absolute bioavailability of nifedipine.

Authors:  T J Rashid; U Martin; H Clarke; D G Waller; A G Renwick; C F George
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

7.  Comparative effects of felodipine, nitrendipine and nifedipine in healthy subjects: concentration-effect relationships of racemic drugs and enantiomers.

Authors:  P A Soons; A F Cohen; D D Breimer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics.

Authors:  P A Soons; T M Mulders; E Uchida; H C Schoemaker; A F Cohen; D D Breimer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  The distribution and gender difference of CYP3A activity in Chinese subjects.

Authors:  Bing Zhu; Zhao-Qian Liu; Guo-Lin Chen; Xiao-Ping Chen; Dong-Sheng Ou-Yang; Lian-Sheng Wang; Song-Lin Huang; Zhi-Rong Tan; Hong-Hao Zhou
Journal:  Br J Clin Pharmacol       Date:  2003-03       Impact factor: 4.335

10.  The pharmacokinetics of oral nifedipine--a population study.

Authors:  A G Renwick; D R Robertson; B Macklin; V Challenor; D G Waller; C F George
Journal:  Br J Clin Pharmacol       Date:  1988-06       Impact factor: 4.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.